NP CHRONICLES
Clinical Education for NP Students & New Grads
CLINICAL DEEP DIVE • CARDIOLOGY / NEUROLOGY
Cardiovascular Disease and Alzheimer's Risk: The Subtype That Surprised Researchers
The link between heart health and brain health is well established in a general sense — but a new study published in the Journal of the American Heart Association asked a sharper question: does it matter which cardiovascular condition a patient has? Using two massive biobanks covering nearly 800,000 people combined, researchers found that most forms of cardiovascular disease (CVD) raise the odds of Alzheimer's disease (AD) — but the strongest association wasn't with the condition most clinicians would guess.
That condition is hypotension, a diagnosis that gets far less attention in dementia-prevention conversations than hypertension does. This post breaks down what the study found, which CVD subtypes mattered most, and what it means for how we think about vascular risk factors in cognitive decline.
The Study: Two Biobanks, 11 CVD Subtypes, One Question
Researchers analyzed cross-sectional data from the UK Biobank (502,133 participants) and the U.S.-based All of Us Research Program (287,011 participants), examining associations between AD and 10 to 11 CVD subtypes identified via ICD-10 codes: hypertension, hypotension, angina pectoris, acute myocardial infarction (AMI), pulmonary embolism, cardiac arrhythmia, heart failure, chronic rheumatic heart disease, chronic ischemic heart disease, and cerebral infarction. Models were adjusted for age, sex, smoking, education, depression, physical activity, alcohol use, ethnicity, BMI, income, and type 2 diabetes status. Researchers also examined shared genetic architecture between AD and CVD traits using genome-wide association study (GWAS) data.
The Standout Finding: Hypotension, Not Hypertension
Hypertension has been studied extensively as a modifiable AD risk factor for decades. Hypotension has not — despite this study finding it had the strongest and most consistent association with AD in both cohorts. In the UK Biobank, hypotension carried an odds ratio of 2.74 for AD; in All of Us, the odds ratio was 1.97. Both figures were notably higher than hypertension's own significant associations (OR 1.57 in UKB, OR 1.65 in All of Us).
The proposed mechanism differs from the small-vessel-damage pathway typically discussed with hypertension. Chronic and orthostatic hypotension have been linked to cerebral hypoperfusion, oxidative stress, and tau pathology — mechanisms that could directly accelerate AD progression rather than simply correlating with it. The authors also note the relationship may run in both directions: AD-related dysfunction of the autonomic nervous system can itself impair blood pressure regulation, so hypotension may be both a contributor to and a consequence of underlying neurodegeneration.
Clinical Bottom Line
Hypotension deserves a bigger place in your cognitive-risk conversations than it currently gets. It showed a stronger and more consistent association with Alzheimer's disease than hypertension across two large, independent cohorts — yet it remains comparatively understudied and easy to overlook, especially in older adults where low blood pressure readings are sometimes dismissed as unremarkable.
Hypertension and Cerebral Infarction: Confirmed, Not Surprising
Hypertension and cerebral infarction both showed strong, consistent associations with AD in both cohorts (cerebral infarction: OR 1.49 in UKB, OR 1.85 in All of Us), which lines up with the well-established literature connecting these conditions to vascular pathology, white matter damage, and cognitive decline. Cardiac arrhythmias were also significantly associated with AD in both cohorts, consistent with arrhythmias' known links to stroke risk and independent associations with cognitive impairment.
The Notable Non-Finding: Acute MI
Acute myocardial infarction (AMI) was not significantly associated with AD in either cohort — a finding the authors describe as consistent with prior research suggesting AMI's direct link to AD pathology remains limited, even though it may contribute to cognitive decline through other pathways like systemic inflammation or hypoxia. Chronic rheumatic heart disease also showed no significant association, possibly because it tends to be an early-stage condition that only raises AD-relevant risk once it progresses to other complications like arrhythmias.
| CVD Subtype | UK Biobank OR | All of Us OR |
|---|---|---|
| Hypotension | 2.74 | 1.97 |
| Cerebral infarction | 1.49 | 1.85 |
| Hypertension | 1.57 | 1.65 |
| Cardiac arrhythmia | 1.52 | Significant |
| Acute myocardial infarction | 1.01 (NS) | 1.09 (NS) |
| Chronic rheumatic heart disease | 1.13 (NS) | 1.12 (NS) |
NS = not statistically significant. ORs adjusted for demographic, lifestyle, and clinical covariates.
Case From Practice
A 74-year-old patient with a history of orthostatic hypotension presents for a routine visit. Blood pressure is well-controlled and the patient denies falls or dizziness, so the hypotension is noted but not discussed further. Based on this research, this is a missed opportunity: hypotension carried a stronger association with Alzheimer's disease than any other CVD subtype studied. This doesn't mean every hypotensive patient needs a dementia workup, but it's a reasonable prompt to include cognitive screening as part of routine care for patients with a hypotension diagnosis, particularly as they age.
The Genetics: Shared Loci Between Heart and Brain
Beyond the phenotypic associations, researchers identified 164 unique pairs of genetic variants located close together on the genome that were independently linked to both CVD and AD traits — suggesting shared biological pathways rather than coincidental co-occurrence. The most notable overlaps:
- 19q13.32 (APOE region): includes APOE, TOMM40, and related genes tied to lipid metabolism — already the most well-established genetic risk locus for AD, now also linked to multiple cardiovascular traits
- 17q21.31 (MAPT region): linked to both AD risk and left ventricular wall thickness
- 11p11.2: genes here (PSMC3, SPI1, RAPSN) are implicated in neuroinflammation, immune response, and cardiac structure
The authors are careful to frame these genetic findings as hypothesis-generating rather than proof of a causal mechanism — this was a proximity-based analysis, not a formal causal-inference method like Mendelian randomization. Still, it strengthens the case that heart and brain pathology may share biological roots rather than simply co-occurring due to shared lifestyle risk factors.
The Risk Isn't Uniform Across Populations
When researchers stratified results by race and ethnicity, the pattern shifted. Hypotension had the strongest AD association in the White cohort, but hypertension had the strongest relationship in Black and Hispanic populations — a pattern the authors suggest may reflect higher rates of uncontrolled hypertension and greater socioeconomic barriers to treatment in those groups. Associations between CVD and AD were also generally stronger in Black and Hispanic populations than in White populations across multiple subtypes.
Nuance to Watch
This is a cross-sectional study — it identifies associations, not causation, and the direction of the hypotension-AD relationship can't be determined from this design alone. Diagnoses were also based on ICD-10 codes, which have high specificity but lower sensitivity, meaning some true cases of CVD or AD were likely missed. And when researchers adjusted for CVD comorbidities together, AMI and chronic rheumatic heart disease flipped to negative associations with AD — a result the authors themselves flag as likely reflecting model instability from overlapping conditions rather than a genuine protective effect. Don't over-interpret single-subtype odds ratios without this context.
Why This Matters for Practice
This study reinforces that "vascular risk" isn't a single, uniform category when it comes to dementia prevention. Hypertension management remains important, but this research suggests hypotension — often treated as a benign or even reassuring finding — deserves more clinical attention as a marker of cognitive risk, particularly in older White patients. It also supports individualized risk stratification: a Black or Hispanic patient with poorly controlled hypertension may carry a different weighted cognitive risk profile than a White patient with chronic hypotension, even though both fall under the broad umbrella of "cardiovascular disease."
Board Prep: Key Points to Lock In
- Across two large biobanks (UK Biobank, n=502,133; All of Us, n=287,011), most CVD subtypes were significantly associated with higher odds of Alzheimer's disease
- Hypotension showed the strongest and most consistent association with AD in both cohorts (UKB OR 2.74; All of Us OR 1.97) despite being comparatively understudied compared to hypertension
- Hypertension and cerebral infarction were also strongly and consistently associated with AD in both cohorts
- Acute myocardial infarction and chronic rheumatic heart disease were NOT significantly associated with AD in either cohort
- Genetic analysis found shared loci between CVD and AD traits, notably near APOE (19q13.32), MAPT (17q21.31), and 11p11.2
- Hypotension's association with AD was strongest in White populations; hypertension's association was strongest in Black and Hispanic populations
- This is a cross-sectional study based on ICD-10 codes — it cannot establish causation or direction of the relationship
Board Prep Quiz
Cardiovascular Disease Subtypes & Alzheimer's Risk
Question 1 of 6
You scored
Frequently Asked Questions
What did this study find about heart disease and Alzheimer's risk?
Using data from two large biobanks covering nearly 800,000 people, researchers found that most cardiovascular disease subtypes were significantly associated with higher odds of Alzheimer's disease. Hypotension showed the strongest and most consistent association, followed by hypertension and cerebral infarction.
Why is hypotension's link to Alzheimer's notable?
Hypertension has been studied extensively as a modifiable Alzheimer's risk factor, but hypotension has received far less research attention despite showing a stronger and more consistent association with Alzheimer's disease in this study. Researchers suggest this may reflect reduced blood flow to the brain and related biological changes over time.
Does having a heart attack increase Alzheimer's risk?
In this study, acute myocardial infarction was not significantly associated with Alzheimer's disease in either biobank, which is consistent with prior research suggesting its direct link to Alzheimer's pathology is limited, even though it may affect cognition through other pathways.
Does this study prove that cardiovascular disease causes Alzheimer's?
No. This was a cross-sectional study, meaning it can identify associations but cannot establish that one condition causes the other or determine the direction of the relationship. The authors describe their findings as hypothesis-generating and note that further research using causal inference methods is needed.
Are these cardiovascular-Alzheimer's risks the same across different racial and ethnic groups?
No. Hypotension had the strongest association with Alzheimer's disease in the White cohort, while hypertension had the strongest association in Black and Hispanic populations. Associations between cardiovascular disease and Alzheimer's disease were also generally stronger in Black and Hispanic populations than in White populations.
References
Toyli A, Zhao C, Su KJ, Shen H, Deng HW, Chen QH, Sha Q, Zhou W. Cardiovascular disease subtypes and Alzheimer's disease: phenotypic and genetic associations in the UK Biobank and All of Us Research Program. J Am Heart Assoc. 2026;15:e046172.
This post is for clinical education purposes for NP students and new graduates and is not a substitute for individualized clinical judgment or institutional protocol.
